Clinical Trials in Illinois

Showing 3221-3240 of 9,411 trials

Hypertrophic Cardiomyopathy Federated Learning Implementation Platform

NCT06461468

HCM FLIP study is a two-phase protocol focusing on the detection of Hypertrophic Cardiomyopathy using Electrocardiograms and Echocardiograms through Federated Learning.

Hypertrophic Cardiomyopathy

American Heart Association1,000 participantsStarted Jun 2024

Fairhope, Alabama, United States • Kankakee, Illinois, United States • Baltimore, Maryland, United States +3 more locations

TERMINATEDPhase 2125 miles

A Study to Assess the Effects of RO6889450 (Ralmitaront) in Participants With Schizophrenia or Schizoaffective Disorder and Negative Symptoms

NCT03669640

This study investigates the effects of RO6889450 on the negative symptoms associated with schizophrenia and schizoaffective disorder.

Schizophrenia, Schizoaffective Disorder

Hoffmann-La Roche131 participantsStarted Dec 2018

Bellflower, California, United States • Garden Grove, California, United States • Glendale, California, United States +42 more locations

Hypertrophic Cardiomyopathy Federated Learning Implementation Platform

A Study to Assess the Effects of RO6889450 (Ralmitaront) in Participants With Schizophrenia or Schizoaffective Disorder and Negative Symptoms

Find Trials by Condition in Illinois

Study to Evaluate Biological & Clinical Effects of Significantly Corrected CFTR Function in Infants & Young Children

A Study Of PF-06463922 An ALK/ROS1 Inhibitor In Patients With Advanced Non Small Cell Lung Cancer With Specific Molecular Alterations

A Study of ZN-c5 in Subjects With Breast Cancer

HAART Annuloplasty Device Valve Repair Registry

Voxelotor Brain Oxygenation and Neurocognitive Study

TPI 287 in Patients With Refractory or Recurrent Neuroblastoma or Medulloblastoma

Randomized Efficacy Study of TPI 287 to Treat Primary Refractory or Early Relapsed Neuroblastoma

Elranatamab Expanded Access Protocol in Adults With Relapsed/Refractory Multiple Myeloma

A Study of Atezolizumab (Anti-PD-L1 Antibody) in Combination With Enzalutamide in Participants With Metastatic Castration-Resistant Prostrate Cancer (mCRPC) After Failure of an Androgen Synthesis Inhibitor And Failure of, Ineligibility For, or Refusal of a Taxane Regimen

Safety Study for Refractory or Relapsed Neuroblastoma With DFMO Alone and in Combination With Etoposide

Erivedge (Vismodegib) in the Treatment of Pediatric Patients With Refractory Pontine Glioma

Efficacy and Safety of Vibrant Capsule vs. Placebo for the Treatment of Chronic Idiopathic Constipation

An Open-Label, Multiple-Center, Phase IIa/IIb Clinical Trial to Evaluate the Efficacy, Safety and Tolerability of VG161 as Monotherapy and in Combination With Nivolumab for Treatment of Patients With Hepatocellular Carcinoma or Intrahepatic Cholangiocarcinoma

Efficacy, Safety, and Tolerability of Gebasaxturev (V937) Administered Intravenously or Intratumorally With Pembrolizumab (MK-3475) Versus Pembrolizumab Alone in Participants With Advanced/Metastatic Melanoma (V937-011)

Training for Health Professionals In Tanzania

Testing the Addition of an Experimental Medication MK-3475 (Pembrolizumab) to Usual Anti-Retroviral Medications in Patients With HIV and Cancer

A Study of Cemdisiran in Adults With Immunoglobulin A Nephropathy (IgAN)

Project Health: Enhancing Effectiveness of a Dissonance-Based Obesity Prevention Program